
Join to View Full Profile
1515 Holcombe BlvdUnit 462Houston, TX 77030
Phone+1 224-301-7002
Dr. Fisch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am board certified in medical oncology, internal medicine and hospice and palliative medicine. I work full-time as Senior Medical Director of Oncology Programs and Genetics at Carelon Medical Benefits Management, a subsidiary of Elevance Health.
I work part-time as Clinical Professor in the Department of General Oncology at MD Anderson Cancer Center in Houston, Texas. I am also Co-Chair of the Symptom Control and QOL Committee for the SWOG Cancer Research Network.
Education & Training
Indiana University School of MedicineFellowship, General Oncology, 1995 - 1997
Indiana UniversityMPH, Health Education, 1997
Indiana UniversityMPH, Health Education, 1997
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1993 - 1996
University of Virginia Medical CenterResidency, Internal Medicine, 1990 - 1993
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2001 - 2027
VA State Medical License 1997 - 2026
IN State Medical License 1993 - 1997
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Vicente Valero LBJ Clinician Educator of the Year MD Anderson Cancer Center, 2019
- Fellow of the American Society of Clinical Oncology ASCO, 2016
- Director's Service Award National Cancer Institute, 2014
Clinical Trials
- Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy Start of enrollment: 2003 May 20
- Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer
- Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer Start of enrollment: 2006 Mar 14
Publications & Presentations
PubMed
- 5 citationsAcademic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial.Anand P Jillella, Sandra J Lee, Jessica K Altman, Selina M Luger, Martin S Tallman
JAMA Oncology. 2025-02-27 - 2 citationsNeighborhood socioeconomic deprivation and patient-reported outcomes in symptom management trials for women with breast cancer.Riha Vaidya, Cathee Till, N Lynn Henry, Michael J Fisch, Dawn L Hershman
Breast Cancer Research and Treatment. 2025-02-01 - 2 citationsAssociation of Participation in Medicare's Oncology Care Model With Spending, Utilization, and Quality Outcomes Among Commercially Insured and Medicare Advantage Members.Samyukta Mullangi, Benjamin Ukert, Andrea Devries, David Debono, Jason Santos
Journal of Clinical Oncology. 2025-01-10
Journal Articles
- Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women with Early-Stage Breast CancerA Randomized Clin...Dawn L Hershman, Jillian L Capodice, William H Kreisle, Michael J Fisch, Marianne K Melnik, Alice T Kengla, Carla W Jorgensen, Heather Greenlee, JAMA
- Patient-oncologist alliance as protection against suicidal ideation in young adults with advanced cancerTrevino KM, Abbott CH, Fisch MJ, Friedlander RJ, Duberstein PR, Prigerson HG, Cancer, 5/1/2014
- Determinants of pain severity changes in ambulatory cancer patients: An analysis from ECOG E2Z02Zhao F, Chang VT, Cleeland C, Cleary JF, Mitchell EP, Wagner LI, Fisch MJ, J Clin Oncol, 2/1/2014
Books/Book Chapters
Abstracts/Posters
- Prediction and early detection of anthracycline-related cardiotoxicity using cardiac biomarkers.Stevens, PL, Lenihan DJ, Ky B, Warneke CL, Johnson MM, Abramson VG, Mayer IA, Adams PT, Campbell MG, Cheema PS, Moore DF, Yeshwant C, Carver JR, BFisch M, J Clin Oncol, 6/1/2014
- Factors asociated with loss of employment among metastatic patients.Tevaarwerk A, Lee JW, Sesto ME, Terhaar A, Smith ML, Cleeland CS, Wagner LI, Fisch M., J Clin Oncol, 5/1/2014
- Clinical risk prediction in anthracycline cardiotoxicity.Ky B, Wameke CL, Lenihan DJ, Cheema PS, Moore DF, Campbell MG, YeshwantC, Adams PT, Krone R, Carver JR, Nasta S, Svoboda J, Schuster SJ, Reddy NM, Patel SM, Rieber AG,..., J Clin Oncol, 5/1/2014
Lectures
- The use of optimal evidence-based chemotherapy (chemo) regimens in physician offices versus hospital outpatient facilities.ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
- Teaching Critical Thinking and Digital Literacy to Solve Real Problems.Chicago, IL - 11/11/2014
- Pearls From the Lens of an Academic General OncologistMD Anderson Cancer Center, Houston, TX - 7/8/2014
Authored Content
- Caring and Learning from Every Patient and Ourselves at ASCOJune 2019
- Caring and Learning from Every Patient and Ourselves at ASCOJune 2019
Press Mentions
Tumor Is Not the Only Target: Ensuring Equitable Person-Centered Supportive Care in the Era of Precision MedicineJune 1st, 2024
A First-of-Its-Kind Opportunity to Integrate Training in Medical Oncology, Hematology, and Palliative CareJune 10th, 2022
10 Twitter Accounts to Follow for Biotech UpdatesJanuary 29th, 2021
Committees
- Member (through 2019), Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) 2016 - 2016
- Member, Ad Hoc Quality Plan Committee 2013 - 2015
- Member, Clinical Faculty Review (Promotion) Committee 2013 - 2015
- Member, Co-Chair (2014), Patient Experience Steering Committee 2012 - 2015
- Member, Physician Relations Faculty Advisory Board 2012 - 2015
Professional Memberships
- Fellow
- Fellow
- Member
- Member
External Links
- AIM Websitehttps://aimspecialtyhealth.com/team/michael-j-fisch-md-mph-facp-faahpm-fasco/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









